Application

14966759 · Botulinum Toxin for Primary Disorders of Mood and Affect using Neurotransmitter CNS imaging Studies

Filed 2015-12-11 · Abandoned The official file ↗ · Art unit 1649 · Examiner Aditi Dutt Hard · CPC A61K 38/4893 · Revance Therapeutics, Inc. · BALLARD SPAHR LLP

Office actions

first was Restriction requirement

RCEs

appealed

To first action

19.7 mo

to disposition 74.2 mo

Statutes raised

103 112 DP

4 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.